Dr. Hart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Patroon Creek Blvd
Ste 210
Albany, NY 12206Phone+1 518-459-8106Fax+1 518-262-6261
Summary
- I am a board-certified neurologist, practicing in Albany, NY since 1993. I did my residency at University of Maryland, where I was administrative chief resident in 1990-1991, and did fellowships in Neuroepidemiology at NIH/National Institute of Neurologic Disorders and Stroke, and EMG/Neuromuscular Disease at University of Maryland. After over 20 years in private practice in Albany my partners and I joined the Faculty Practice Group at Albany Medical College, in April 2014. I have been involved in clinical research since the late 1990's, and over that time have developed a strong interest and extensive clinical research experience in Alzheimer's disease and related disorders, and am director of research for AMC Community Neurology. I practice at AMC Community Neurology/The Neurology Group's offices in Albany and Clifton Park, NY and at Albany Medical College's Alzheimer's Center in Albany.
Education & Training
- University of Maryland Medical CenterEMG/Neuromuscular Disease, 1992 - 1993
- Clinical Center at the National Institutes of HealthFellowship, Neuroepidemiology, 1991 - 1992
- University of MarylandResidency, Neurology, 1988 - 1991
- University of MarylandInternship, Internal Medicine, 1987 - 1988
- Rutgers New Jersey Medical SchoolClass of 1987
Certifications & Licensure
- NY State Medical License 1993 - 2026
- MD State Medical License 1988 - 1994
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Acumen nEHR, Health IT Services Group, 2012
- Fellow American Academy of Neurology, 2011
Clinical Trials
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 35 citationsChildhood Guillain-Barré syndrome in Paraguay, 1990 to 1991.David E. Hart, Laura A. Rojas, Joana A. Rosàrio, Humberto Recalde, Gustavo C. Román
Annals of Neurology. 1994-12-01
Press Mentions
- Alzheimer’s Awareness: Neurologist on Treatment and PreventionJune 16th, 2022
- Local Alzheimer’s Patient, Doctor React to FDA Approval for New Drug TherapyJune 8th, 2021
- Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: